key: cord-0963900-qz0ns07n
authors: Baker, Forrest L.; Smith, Kyle A.; Zúñiga, Tiffany M.; Batatinha, Helena; Niemiro, Grace M.; Pedlar, Charles R.; Burgess, Shane C.; Katsanis, Emmanuel; Simpson, Richard J.
title: Acute exercise increases immune responses to SARS CoV-2 in a previously infected man
date: 2021-09-08
journal: Brain Behav Immun Health
DOI: 10.1016/j.bbih.2021.100343
sha: 76dd9c3386a1937dd6847a263b434a89a4763229
doc_id: 963900
cord_uid: qz0ns07n

Evidence is emerging that exercise and physical activity provides protection against severe COVID-19 disease in patients infected with SARS-CoV-2, but it is not known how exercise affects immune responses to the virus. A healthy man completed a graded cycling ergometer test prior to and after SARS-CoV-2 infection, then again after receiving an adenovirus vector-based COVID-19 vaccine. Using whole blood SARS-CoV-2 peptide stimulation assays, IFN-γ ELISPOT assays, flow cytometry, ex vivo viral-specific T-cell expansion assays and deep T-cell receptor (TCR) β sequencing, we found that exercise robustly mobilized highly functional SARS-CoV-2 specific T-cells to the blood compartment that recognized spike protein, membrane protein, nucleocapsid antigen and the B.1.1.7 α-variant, and consisted mostly of CD3+/CD8+ T-cells and double-negative (CD4-/CD8-) CD3+ T-cells. The magnitude of SARS-CoV-2 T-cell mobilization with exercise was intensity dependent and robust when compared to T-cells recognizing other viruses (e.g. CMV, EBV, influenza). Vaccination enhanced the number of exercise-mobilized SARS-CoV-2 T-cells recognizing spike protein and the α-variant only. Exercise-mobilized SARS-CoV-2 specific T-cells proliferated more vigorously to ex vivo peptide stimulation and maintained broad TCR-β diversity against SARS-CoV-2 antigens both before and after ex vivo expansion. Neutralizing antibodies to SARS-CoV-2 were transiently elevated during exercise after both infection and vaccination. Finally, infection was associated with an increased metabolic demand to defined exercise workloads, which was restored to pre-infection levels after vaccination. This case study provides impetus for larger studies to determine if these immune responses to exercise can facilitate viral clearance, ameliorate symptoms of long COVID syndrome, and/or restore functional exercise capacity following SARS-CoV-2 infection.

Evidence is emerging that exercise and physical activity provides protection against severe 23 COVID-19 disease in patients infected with SARS-CoV-2, but it is not known how exercise affects 24 immune responses to the virus. A healthy man completed a graded cycling ergometer test prior to 25 and after SARS-CoV-2 infection, then again after receiving an adenovirus vector-based COVID-26 19 vaccine. Using whole blood SARS-CoV-2 peptide stimulation assays, IFN- ELISPOT assays, 27 flow cytometry, ex vivo viral-specific T-cell expansion assays and deep T-cell receptor (TCR)  28 sequencing, we found that exercise robustly mobilized highly functional SARS-CoV-2 specific T-29 cells to the blood compartment that recognized spike protein, membrane protein, nucleocapsid Neutralizing antibodies to SARS-CoV-2 were transiently elevated during exercise after both 38 infection and vaccination. Finally, infection was associated with an increased metabolic demand 39 to defined exercise workloads, which was restored to pre-infection levels after vaccination. This 40 case study provides impetus for larger studies to determine if these immune responses to exercise 41 J o u r n a l P r e -p r o o f

As of August 5th 2021, the coronavirus disease of 2019 (COVID-19) pandemic caused by the 49 severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has infected more than ~200 50 million people worldwide resulting in over 4.2 million deaths (Dong et al., 2020) . The rapid 51 development and distribution of vaccine candidates has seen more than 4.3 billion vaccine doses 52 administered to date, lowering rates of infection and mortality. It has been reported, however, that 53 10-30% of COVID-19 survivors will develop so-called long COVID syndrome, experiencing 54 continuing symptoms of disease such as fatigue, shortness of breath, "brain fog", fever, anxiety, 55 depression, sleep disorders and gastrointestinal problems (Logue et al., 2021; Sudre et al., 2021; 56 Yong, 2021) . The causes of long COVID syndrome are not yet known, but viral persistence and/or 57 a prolonged inflammatory response are likely to be involved (Yong, 2021) . 58

It has emerged that lifestyle factors are playing a role in disease severity following SARS-CoV-2 59 infection, with those who are obese and/or physically inactive more likely to die, become 60 We demonstrate in an otherwise healthy man that acute exercise transiently increases circulating 80 neutralizing antibodies and instantaneously mobilizes highly functional SARS-CoV-2 specific T-81 cells after natural infection and again following COVID-19 vaccination. We also report that natural 82 infection increased the metabolic response to defined exercise workloads, which was reversed after 83 COVID-19 vaccination. This case study provides impetus for future research to determine if the 84 frequent mobilization and redistribution of SARS-CoV-2 specific T-cells and increased 85 transportation of neutralizing antibodies with each bout of exercise can increase viral clearance, 86 ameliorate symptoms of long COVID syndrome, and/or restore functional exercise capacity after 87 infection. 

SARS-CoV-2 VSTs were expanded from PBMCs in the Post-I trial only using a previously 151 described VST expansion protocol (Keller et al., 2020) . Briefly, 1x10 7 PBMCs were pulsed with 152 700ng each of S, M, and N SARS-CoV-2 pepmix pools (JPT) in 100µL RPMI culture medium 153 consisting of 10% fetal bovine serum and 1% penicillin-streptomycin for 1h at 37˚C with 5% CO2. 154

After incubation, culture media supplemented with IL-4 (1000IU/mL) and IL-7 (10ng/mL) was 155 added to a final concentration of 1x10 6 cells/mL culture medium and cells were placed within gas 156 permeable G-REX devices for 7-days. On day 7, cells were enumerated and resuspended at 1x10 6 157 cells/mL in media supplemented with IL-4 (1000IU/mL), IL-7 (10ng/mL), and IL-15 (5ng/mL) 158 until day 10 whereby cells were harvested, enumerated, phenotyped, and used for functional 159 assays. 160 J o u r n a l P r e -p r o o f 161

The number of functional SARS-CoV-2 specific T-cells producing IFN-γ in response to virus-163 specific peptide stimulation were determined by enzyme-linked immunospot (ELISPOT) assays 164 (Mabtech AB, Sweden) as previously described (Keller et Specifically, exercise increased the whole blood IFN-γ response to pooled SARS-CoV-2 pepmix 199 stimulation in an intensity dependent manner (Figure 1a) . These results were corroborated via IFN-200 γ SFCs measured by ELISPOT (Figure 1a ) (the alpha-variant pepmix was not used to stimulate 201 whole blood in the Post-I trial as they were not available at this time). There was an enhanced IFN-202 γ response after exercise Post-V, but not in an intensity dependent manner (Figure 1a) . A similar 203 exercise response was observed with SARS-CoV-2 specific neutralizing antibodies (Figure 2b) . 204

The IFN-γ response to peptide stimulation (whole blood and ELISPOT) was increased after 205 exercise in the Post-I trial with the strongest effect seen for T-cells recognizing S protein (and -206 variant), followed by M, and then N structural proteins (Figure 1c) . The IFN-γ response to peptide 207 stimulation (whole blood and ELISPOT) increased at the 60% intensity Post-V, with the strongest 208 effect seen for T-cells recognizing S protein (and -variant), followed by N, and then M structural 209 proteins (Figure 1d ). In the Post-I trial, the absolute change in IFN- secretion to combined SARS-210

CoV-2 whole blood peptide stimulation was greater than that observed after stimulating with 211 

The effect of exercise on the ex vivo expansion of SARS-CoV-2 VSTs in the Post-I trial is depicted increased lymphatic transportation of neutralizing antibodies, is one potential mechanism by which 256 exercise can improve immunity against SARS-CoV-2 (Simpson and Katsanis, 2020); but how 257 exercise affects cellular and humoral immunity against this novel coronavirus has not been 258 determined. This case study is the first report of immune responses to exercise following SARS-259

We have previously shown that T-cells specific to adenovirus and common herpesviruses 261 (CMV,EBV) are mobilized to blood in response to acute exercise, and that the effect is largely 262 influenced by the secretion of catecholamines acting on T-cell 2 adrenergic receptors (Kunz et The enhanced whole blood IFN- response to SARS-CoV-2 peptides during exercise appears 280 largely due to increased numbers of SARS-CoV-2 T-cells in blood, as highly sensitive IFN- 281 ELISPOT assays showed that exercise increased total T-cell numbers (adjusted per volume of 282 whole blood) recognizing all four of the SARS-CoV-2 antigen peptide pools used in this study. performance was facilitated by the vaccine, the exercise habits of the individual, or to more 327 recovery time following infection warrants further investigation. The participant did, however, 328 report that he was still experiencing afternoon tiredness even after receiving the vaccine. It is 329 possible that the increased fatigue/tiredness is associated with the elevated baseline cortisol levels 330 that were observed after both infection and vaccination (Kumari et al., 2009 ). Cortisol did not 331 increase during exercise, which is typical for individuals of high fitness performing relatively short 332 bouts (<20-minutes) of exercise (Duclos et al., 1997) . There did, however, appear to be a 'cortisol 333 clearance' effect of exercise when baseline levels were high following SARS CoV-2 infection and 334

In conclusion, the findings from this case study indicate that a single exercise bout mobilizes large 336 numbers of SARS-CoV-2 specific T-cells with broad TCR diversity against COVID antigens and 337 an enhanced ability to respond to recall antigens. Notwithstanding the obvious limitations of a case 338 study (e.g. limited sample size, lack of statistical sampling, low external validity, limited control 339 conditions), the findings do support the narrative that every exercise bout promotes neutralizing 

ACSM's 388 guidelines for exercise testing and prescription

Are vaccines safe in 390 patients with Long COVID? A prospective observational study. medRxiv

Factors associated with COVID-19 related hospitalisation, critical care admission and 394 mortality using linked primary and secondary care data. Influenza and other respiratory viruses

Association of physical activity levels and the 397 prevalence of COVID-19-associated hospitalization

COVID-400 19, an emerging coronavirus infection: advances and prospects in designing and developing 401 vaccines, immunotherapeutics, and therapeutics

An interactive web-based dashboard to track COVID-19 in real 404 time

Trained versus untrained 406 men: different immediate post-exercise responses of pituitary adrenal axis

Syndrome and the Potential Benefits of Exercise

SARS-CoV-2-specific T cells are rapidly 416 expanded for therapeutic use and target conserved regions of the membrane protein

Exercise-induced 419 redistribution of T lymphocytes is regulated by adrenergic mechanisms

Cortisol secretion and fatigue: associations in a community based cohort

The effects of β(1) and 426 β(1+2) adrenergic receptor blockade on the exercise-induced mobilization and ex vivo expansion 427 of virus-specific T cells: implications for cellular therapy and the anti-viral immune effects of 428 exercise

A single 430 exercise bout augments adenovirus-specific T-cell mobilization and function

Sequelae in Adults at 6 Months After COVID-19 Infection

Rehabilitation Exercise and psycholoGical 438 support After covid-19 InfectioN' (REGAIN): a structured summary of a study protocol for a 439 randomised controlled trial

The effects of acute moderate exercise on lymphocyte function and serum immunoglobulin 442 levels

Prior SARS-CoV-2 infection rescues B and T cell responses to variants after first 447 vaccine dose

Physical 449 inactivity is associated with a higher risk for severe COVID-19 outcomes: a study in 48 440 adult 450 patients

The immunological case for staying active during the COVID-19 452 pandemic

The effects of age and latent cytomegalovirus infection on the redeployment 455 of CD8+ T cell subsets in response to acute exercise in humans

A single exercise bout 457 enhances the manufacture of viral-specific T-cells from healthy donors: implications for 458 allogeneic adoptive transfer immunotherapy

Attributes and predictors of long COVID

Rehabilitation in adult post-465 COVID-19 patients in post-acute care with Therapeutic Exercise

Position statement. Part two: Maintaining immune health. Exerc 469

Long COVID or post-COVID-19 syndrome: putative pathophysiology, risk factors, 471 and treatments